Search
Displaying 661–670 of 929 results for “vision connection”
-
Eye on the Cure Podcast | Episode 40: Rebecca Alexander
Eye on the CureFebruary 10, 2023. Rebecca Alexander talks candidly with host Ben Shaberman about her journey with Usher syndrome. Reflecting on her own experiences, she discusses how people with vision loss and their loved ones can practice good emotional care and advocate for their needs.
-
Retinal Research Community Loses Beloved Pioneer Sam Jacobson
Beacon StoriesHis many contributions included pivotal work that led to LUXTURNA
-
Hello my name is Josephine Ortega , I am a college student continuing her passion of art despite me being visually impaired. I was diagnosed with Stargardt disease when I was a child. A rare genetic eye disease that loses the central vision overtime as a child to adulthood.
-
Opus Genetics to Launch Gene Therapy Clinical Trial for LCA5 Patients
Research NewsThe LCA5 gene therapy will be the first emerging Opus treatment to move into a human study
-
Recap of Retinal Disease News from the 2022 Meeting of the American Academy of Ophthalmology
Research NewsReports on emerging therapies for dry age-related macular degeneration (geographic atrophy), Stargardt disease, and X-linked retinitis pigmentosa are included
-
To help spread awareness during October Blindness Awareness Month, we’re inviting you to share your vision-loss journey through written word, audio or video as a part of our October “Share Your Vision” campaign. Visit www.FightingBlindness.org/ShareYourVision to learn more.
-
To help spread awareness during October Blindness Awareness Month, we’re inviting you to share your vision-loss journey through written word, audio or video as a part of our October “Share Your Vision” campaign. Visit www.FightingBlindness.org/ShareYourVision to learn more.
-
Colin was born in the small Western New York Community of Jamestown. His emersion into the arts started naturally, his mother was a designer and his father an art and antiques collector.
-
RD Fund Participates in a €75 Million Series B for SparingVision
In the PressProceeds to fund first, in-human trials of breakthrough gene-agnostic therapy products and advance CRISPR-based genome editing portfolio.
-
Endogena Launches Clinical Trial of Therapy to Activate Stem Cells in RP Patients’ Retinas
Research NewsThe emerging treatment is gene-agnostic.
.png)
.png)
.png)
